BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 4.480
EU - Europa 3.985
AS - Asia 1.834
SA - Sud America 598
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 39
Totale 10.989
Nazione #
US - Stati Uniti d'America 4.370
RU - Federazione Russa 2.020
SG - Singapore 755
CN - Cina 581
SE - Svezia 540
BR - Brasile 522
IE - Irlanda 492
DE - Germania 221
HK - Hong Kong 196
FR - Francia 137
IT - Italia 132
UA - Ucraina 125
FI - Finlandia 108
GB - Regno Unito 104
VN - Vietnam 94
IN - India 51
CA - Canada 49
AR - Argentina 29
BD - Bangladesh 24
PL - Polonia 22
JP - Giappone 18
MX - Messico 17
IQ - Iraq 15
TR - Turchia 15
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
ES - Italia 13
ID - Indonesia 12
BE - Belgio 11
CO - Colombia 11
MA - Marocco 11
VE - Venezuela 11
EC - Ecuador 10
AT - Austria 9
CR - Costa Rica 8
SA - Arabia Saudita 8
IL - Israele 7
NI - Nicaragua 7
NL - Olanda 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
LV - Lettonia 6
PK - Pakistan 5
TN - Tunisia 5
AZ - Azerbaigian 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GT - Guatemala 4
GY - Guiana 4
HN - Honduras 4
KE - Kenya 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
PH - Filippine 4
SC - Seychelles 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AL - Albania 3
CH - Svizzera 3
CI - Costa d'Avorio 3
NO - Norvegia 3
PS - Palestinian Territory 3
PY - Paraguay 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CL - Cile 2
IR - Iran 2
MD - Moldavia 2
TG - Togo 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
ME - Montenegro 1
MN - Mongolia 1
PA - Panama 1
PE - Perù 1
Totale 10.947
Città #
Ashburn 646
Moscow 526
Chandler 499
Dublin 491
Singapore 419
Dallas 333
Jacksonville 283
San Jose 256
Nyköping 251
Beijing 226
Hong Kong 196
The Dalles 122
Council Bluffs 109
Dearborn 90
Los Angeles 90
Princeton 73
Cambridge 69
Lauterbourg 68
Medford 65
New York 65
Munich 64
Des Moines 57
Ann Arbor 50
Boardman 50
Santa Clara 40
Buffalo 35
Ho Chi Minh City 35
São Paulo 34
Helsinki 27
Bremen 25
Frankfurt am Main 25
Lancaster 23
Atlanta 20
Hanoi 20
San Mateo 20
Tianjin 20
Orem 19
Woodbridge 19
Jinan 18
Seattle 18
Shanghai 17
Tokyo 17
Wilmington 17
Brooklyn 16
Guangzhou 16
Houston 16
North Bergen 16
Warsaw 16
Belo Horizonte 15
Redondo Beach 15
Turku 15
Chicago 14
Brasília 13
Montreal 13
Nanjing 13
Pune 13
Rome 13
Chennai 12
Phoenix 12
Brussels 11
Düsseldorf 11
Denver 10
Porto Alegre 10
Rio de Janeiro 10
Shenyang 10
Boston 9
Curitiba 9
Haikou 9
Hebei 9
Johannesburg 9
Ningbo 9
Augusta 8
Bexley 8
Brno 8
Dhaka 8
Nanchang 8
Stockholm 8
Charlotte 7
Falls Church 7
Hyderabad 7
London 7
Managua 7
Tappahannock 7
Toronto 7
Washington 7
Baghdad 6
Jiaxing 6
Leawood 6
Manchester 6
Mexico City 6
Milan 6
Naples 6
Portsmouth 6
Recife 6
Riga 6
San Francisco 6
Campinas 5
Carapicuíba 5
Kingston 5
Manaus 5
Totale 6.081
Nome #
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 249
Erythropoietin and its lost receptor. 246
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 234
A brief "update" on renal effects of caffeine 224
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 221
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 220
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 217
Dialysis and the Elderly: An Underestimated Problem. 205
Down with the erythropoietin. Long live the erythropoietin! 200
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 197
[Erythropoietin: pleiotropic actions]. 191
Caffeine and the kidney: What evidence right now? 190
A new therapy for kidney injury: regeneration. 188
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 185
Acute cardiovascular complications of hemodialysis. 183
Effects of haemodialysis on circulating endothelial progenitor cell count 181
The erythropoietin and regenerative medicine: a lesson from fish 179
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 177
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 176
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 174
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 173
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 172
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 172
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 171
Aquaretic agents: What's beyond the treatment of hyponatremia? 168
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 162
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 161
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 160
Pregnancy in uremic patients: An eventful journey 156
Therapy with vasopressin receptor antagonists: the aquaretics 156
Erythropoietin and its lost receptor [8] 156
Regenerative medicine: does Erythropoietin have a role? 156
Neurobiological model and quality of life in discovering personality of the uremic patient. 155
Aquaretic-induced apoptosis: a cure or a curse? 155
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 154
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 154
Malnutrition in the elderly patient on dialysis. 152
Renal complications in oncohematologic patients. 151
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 151
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 148
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 145
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 145
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 144
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 143
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 140
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 139
Erythropoietin and cancer: an old risk. 133
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 130
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 128
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 126
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 126
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 124
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 123
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 122
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 121
NGAL is a precocious marker of therapeutic response. 121
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 118
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 115
Genomic damage in endothelial progenitor cells from uremic patients. 110
Pulmonary hypertension and erythropoietin. 109
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 108
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 103
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 101
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 101
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 100
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 99
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 85
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 83
NGAL: a new missing link between inflammation and uremic anemia? 81
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 76
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 69
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 68
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 48
null 39
null 30
null 16
Totale 10.989
Categoria #
all - tutte 36.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022464 0 0 0 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/20251.543 24 14 53 99 43 62 35 296 393 120 150 254
2025/20264.709 277 334 345 265 388 957 610 608 596 147 84 98
2026/20271.061 129 458 236 238 0 0 0 0 0 0 0 0
Totale 10.989